Financial comparisons HBM Healthcare Investments AG
Equities
HBMN
CH0012627250
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 219.00 CHF | +3.06% |
|
+6.31% | +24.43% |
| Dec. 08 | HBM Healthcare Investments Set to Receive Payments from Portfolio Company Sale | MT |
| Dec. 08 | Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 47.4M | 43.99% | 37.66% | - | - | 6.15x | |
| 494M | 53.28% | - | 17.18% | 8.99% | - | |
| 56.33M | -1.83% | 22.94% | -0.06% | - | 3.14x | |
| 252M | 13.43% | - | 3.99% | 1.72% | - | |
| Average | 212M | 27.22% | 30.3% | 7.04% | 5.35% | 4.64x | |
| Weighted average by Cap. | 284M | 38.73% | 32.08% | 11.95% | 8.01% | 5.01x |
- Stock Market
- Equities
- HBMN Stock
- Sector HBM Healthcare Investments AG
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
